Researchers have developed a deep-learning platform called GPS to accelerate de novo drug discovery by analyzing chemical structures to predict how they change gene expression. While traditional methods focus on specific protein targets, this system identifies molecules capable of reversing disease-associated transcriptional phenotypes to restore healthy cellular states. The study demonstrates the...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动